BRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLN

Reuters

03/12

March 12 (Reuters) - OrbusNeich Medical Group Holdings Ltd 6929.HK:

ORBUSNEICH MEDICAL GROUP HOLDINGS FY REVENUE USD 180.5 MILLION
FY PROFIT ATTRIBUTABLE $34.8 MILLION
FINAL DIVIDEND 12 HK CENTS PER SHARE
IN 2026, OVERSEAS REVENUE IS EXPECTED TO CONTINUE ITS STEADY GROWTH
ANTICIPATES REVENUE GROWTH WILL CONTINUE TO ACCELERATE IN 2026
WILL CONTINUE TO REVIEW DIVIDEND POLICY AND EXPLORE POSSIBILITY OF DISTRIBUTING INTERIM DIVIDENDS IN FUTURE.

Further company coverage: 6929.HK

((Reuters.Briefs@thomsonreuters.com;))

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2618713350"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2618713350\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2618713350?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-12 18:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618713350","market":"nz","top_or_hot":-1,"title":"BRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLN","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLN</title></head><body><p><span>March 12 (Reuters)</span><span> - </span>OrbusNeich Medical Group Holdings Ltd <span>6929.HK</span>:</p><ul><li><p>ORBUSNEICH MEDICAL GROUP HOLDINGS FY REVENUE USD 180.5 MILLION</p></li><li><p>FY PROFIT ATTRIBUTABLE $34.8 MILLION</p></li><li><p>FINAL DIVIDEND 12 HK CENTS PER SHARE</p></li><li><p>IN 2026, OVERSEAS REVENUE IS EXPECTED TO CONTINUE ITS STEADY GROWTH</p></li><li><p>ANTICIPATES REVENUE GROWTH WILL CONTINUE TO ACCELERATE IN 2026</p></li><li><p>WILL CONTINUE TO REVIEW DIVIDEND POLICY AND EXPLORE POSSIBILITY OF DISTRIBUTING INTERIM DIVIDENDS IN <a href=\"https://laohu8.com/S/FUTR.UK\">FUTURE</a>.</p></li></ul><p>Further company coverage: <span>6929.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLN</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLN\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2026-03-12 18:28</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLN</title></head><body><p><span>March 12 (Reuters)</span><span> - </span>OrbusNeich Medical Group Holdings Ltd <span>6929.HK</span>:</p><ul><li><p>ORBUSNEICH MEDICAL GROUP HOLDINGS FY REVENUE USD 180.5 MILLION</p></li><li><p>FY PROFIT ATTRIBUTABLE $34.8 MILLION</p></li><li><p>FINAL DIVIDEND 12 HK CENTS PER SHARE</p></li><li><p>IN 2026, OVERSEAS REVENUE IS EXPECTED TO CONTINUE ITS STEADY GROWTH</p></li><li><p>ANTICIPATES REVENUE GROWTH WILL CONTINUE TO ACCELERATE IN 2026</p></li><li><p>WILL CONTINUE TO REVIEW DIVIDEND POLICY AND EXPLORE POSSIBILITY OF DISTRIBUTING INTERIM DIVIDENDS IN <a href=\"https://laohu8.com/S/FUTR.UK\">FUTURE</a>.</p></li></ul><p>Further company coverage: <span>6929.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06929","symbol_name":"業聚醫療","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nPLX51382B:1","article_id":"2618713350","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618713350","pubTimestamp":1773311324,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLNMarch 12  - OrbusNeich Medical Group Holdings Ltd 6929.HK:ORBUSNEICH MEDICAL GROUP HOLDINGS FY REVENUE USD 180.5 MILLIONFY PROFIT ATTRIBUTABLE $34.8 MILLIONFINAL DIVIDEND 12 HK CENTS PER SHAREIN 2026, OVERSEAS REVENUE IS EXPECTED TO CONTINUE ITS STEADY GROWTHANTICIPATES REVENUE GROWTH WILL CONTINUE TO ACCELERATE IN 2026WILL CONTINUE TO REVIEW DIVIDEND POLICY AND EXPLORE POSSIBILITY OF DISTRIBUTING INTERIM DIVIDENDS IN FUTURE.Further company coverage: 6929.HK ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06929":"业聚医疗","BK1222":"医疗保健用品"},"translate_title":"简介-OrbusNeich医疗集团公布财年归属利润为3480万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06929":0.9},"content_text":"BRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLNMarch 12 (Reuters) - OrbusNeich Medical Group Holdings Ltd 6929.HK:ORBUSNEICH MEDICAL GROUP HOLDINGS FY REVENUE USD 180.5 MILLIONFY PROFIT ATTRIBUTABLE $34.8 MILLIONFINAL DIVIDEND 12 HK CENTS PER SHAREIN 2026, OVERSEAS REVENUE IS EXPECTED TO CONTINUE ITS STEADY GROWTHANTICIPATES REVENUE GROWTH WILL CONTINUE TO ACCELERATE IN 2026WILL CONTINUE TO REVIEW DIVIDEND POLICY AND EXPLORE POSSIBILITY OF DISTRIBUTING INTERIM DIVIDENDS IN FUTURE.Further company coverage: 6929.HK ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}